PPSV23

pneumococcal polysaccharide vaccine 23-valent · Merck & Co.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PPSV23, covering 2024-04-04 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial [Phase 2]

See pricing